
Amphenol Corp (APH) stock recently achieved an all-time high of $94.84, following a 37.8% total return over the past year, though InvestingPro data suggests the stock may be overvalued at current levels. The electronics manufacturer maintains a "GREAT" financial health rating with a healthy 1.99 current ratio and moderate debt, recently pricing €600 million and $750 million in senior notes to repay commercial paper and for general corporate purposes. Analysts have responded positively, with Evercore ISI raising its price target to $105 and UBS to $106, both maintaining Buy ratings citing strong performance and growth potential, while Amphenol also declared a Q2 2025 dividend of $0.165 per share.
Amphenol Corp. (APH) has demonstrated significant market strength, reaching an all-time high of $94.84, reflecting a 37.8% total return over the past year and a 32.7% gain in the last six months. Despite this strong momentum, data signals suggest the stock may be overvalued at its current level, trading just 1% below its 52-week peak. Fundamentally, the company is on solid footing, evidenced by a "GREAT" financial health score, a healthy current ratio of 1.99, and moderate debt levels. Confidence from the analyst community is robust, with Evercore ISI and UBS raising their price targets to $105 and $106, respectively, citing positive earnings prospects. The company is actively managing its capital structure, having priced a combined €600 million and $750 million in senior notes to refinance existing debt and for general corporate purposes. Furthermore, Amphenol continues to return capital to shareholders, declaring a second-quarter 2025 dividend of $0.165 per share.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment